{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:45:02Z","timestamp":1791431102983,"version":"4.3.3"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,3,9]]},"DOI":"10.1001\/jama.2021.1195","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T16:32:38Z","timestamp":1615307558000},"page":"952","source":"Crossref","is-referenced-by-count":118,"title":["Prevalence of Central Nervous System\u2013Active Polypharmacy Among Older Adults With Dementia in the US"],"prefix":"10.1001","volume":"325","author":[{"given":"Donovan T.","family":"Maust","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Michigan, Ann Arbor"},{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Strominger","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Myra","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Langa","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Institute for Social Research, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie P. W.","family":"Bynum","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiang-Hua","family":"Chang","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Kales","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California\u2013Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Zivin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan, Ann Arbor"},{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Solway","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Marcus","sequence":"additional","affiliation":[{"name":"School of Social Policy and Practice, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"19","key":"joi210010r1","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"joi210010r2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1377\/hlthaff.2013.1247","article-title":"The long reach of Alzheimer\u2019s disease: patients, practice, and policy.","volume":"33","author":"Bynum","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"joi210010r3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.","volume":"288","author":"Lyketsos","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"joi210010r4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/jgs.1998.46.issue-2","article-title":"Assessing the impact of neuropsychiatric symptoms in Alzheimer\u2019s disease: the Neuropsychiatric Inventory Caregiver Distress Scale.","volume":"46","author":"Kaufer","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"joi210010r5","doi-asserted-by":"publisher","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia.","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"joi210010r6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2020.8519","article-title":"Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US.","volume":"324","author":"Maust","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"joi210010r7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamainternmed.2016.7507","article-title":"Adult utilization of psychiatric drugs and differences by sex, age, and race.","volume":"177","author":"Moore","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"4","key":"joi210010r8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jamainternmed.2016.9225","article-title":"Trends in central nervous system-active polypharmacy among older adults seen in outpatient care in the United States.","volume":"177","author":"Maust","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"4","key":"joi210010r9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.2019.67.issue-4","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.","volume":"67","author":"2019 American Geriatrics Society Beers Criteria Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"joi210010r10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/(ISSN)1532-5415","article-title":"Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging and Body Composition Study.","volume":"57","author":"Wright","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"joi210010r11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"joi210010r12","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"joi210010r13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160828","article-title":"Psychotropic polypharmacy in patients with dementia: prevalence and predictors.","volume":"56","author":"N\u00f8rgaard","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"joi210010r14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","article-title":"Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer\u2019s disease.","volume":"28","author":"Orsel","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"joi210010r15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/gps.v32.7","article-title":"Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study.","volume":"32","author":"Breining","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"joi210010r16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0895-4356(02)00452-3","article-title":"The accuracy of Medicare claims data in identifying Alzheimer\u2019s disease.","volume":"55","author":"Taylor","year":"2002","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"joi210010r17","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1097\/MLR.0000000000000109","article-title":"Algorithm for identifying nursing home days using Medicare claims and Minimum Data Set assessment data.","volume":"54","author":"Wei","year":"2016","journal-title":"Med Care"},{"issue":"3","key":"joi210010r18","first-page":"27","article-title":"More accurate racial and ethnic codes for Medicare administrative data.","volume":"29","author":"Eicheldinger","year":"2008","journal-title":"Health Care Financ Rev"},{"key":"joi210010r20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fneur.2014.00011","article-title":"Mechanisms of levetiracetam in the control of status epilepticus and epilepsy.","volume":"5","author":"Deshpande","year":"2014","journal-title":"Front Neurol"},{"issue":"4","key":"joi210010r21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/gerona\/gln043","article-title":"Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study.","volume":"64","author":"Hanlon","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"joi210010r22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2050-6511-14-56","article-title":"Psychotropic drug use among people with dementia\u2014a six-month follow-up study.","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"issue":"12","key":"joi210010r23","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jagp.2015.07.001","article-title":"Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004-2013.","volume":"23","author":"Vasudev","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11","key":"joi210010r24","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1017\/S1041610216001307","article-title":"Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.","volume":"28","author":"Walsh","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"joi210010r25","doi-asserted-by":"crossref","DOI":"10.1177\/0733464820948328","article-title":"Can a nursing home psychotropic reduction project be successfully implemented in assisted living?","author":"Abrahamson","year":"2020","journal-title":"J Appl Gerontol"},{"key":"joi210010r26","article-title":"Antidepressants for treating depression in dementia.","volume":"8","author":"Dudas","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"joi210010r27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/gps.v32.2","article-title":"Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.","volume":"32","author":"Maust","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"issue":"12","key":"joi210010r28","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1046\/j.1532-5415.2001.49282.x","article-title":"Apathy in Alzheimer\u2019s disease.","volume":"49","author":"Landes","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"joi210010r29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40266-016-0380-3","article-title":"Changing pattern of sedative use in older adults: a population-based cohort study.","volume":"33","author":"Iaboni","year":"2016","journal-title":"Drugs Aging"},{"issue":"2","key":"joi210010r30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.amjopharm.2006.06.006","article-title":"Management of chronic insomnia in elderly persons.","volume":"4","author":"Bain","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"issue":"12","key":"joi210010r31","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1377\/hlthaff.2011.0370","article-title":"False Claims Act prosecution did not deter off-label drug use in the case of Neurontin.","volume":"30","author":"Kesselheim","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"joi210010r32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/11632030-000000000-00000","article-title":"Off-label use of atypical antipsychotics: cause for concern?","volume":"26","author":"McKean","year":"2012","journal-title":"CNS Drugs"},{"issue":"3","key":"joi210010r34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.15420\/aer.2019.8.3.G1","article-title":"British Heart Rhythm Society clinical practice guidelines on the management of patients developing QT prolongation on antipsychotic medication.","volume":"8","author":"Lambiase","year":"2019","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"5","key":"joi210010r35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/gerona\/glz270","article-title":"Association between medications acting on the central nervous system and fall-related injuries in community-dwelling older adults: a new user cohort study.","volume":"75","author":"Gray","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"21","key":"joi210010r36","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons.","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"11","key":"joi210010r37","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults.","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"joi210010r38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimer\u2019s disease: outcomes from CATIE-AD.","volume":"168","author":"Vigen","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"8","key":"joi210010r39","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"key":"joi210010r19","unstructured":"National Library of Medicine, National Center for Biotechnology Information. PubChem. Accessed February 4, 2021. https:\/\/pubchem.ncbi.nlm.nih.gov"},{"key":"joi210010r33","unstructured":"US Food and Drug Administration. FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Published August 31, 2016. Accessed May 10, 2019. https:\/\/www.fda.gov\/media\/99761\/download?"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2777235\/jama_maust_2021_oi_210010_1614735422.71717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T16:32:55Z","timestamp":1615307575000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2777235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,3,9]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.1195","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,9]]}}}